Author: healthadmin

Childhood abuse is associated with accelerated biological aging and a tendency to avoid looking others in the eye. A new study published in PLOS One shows that these physical and behavioral changes occur independently in abused children. Both of these responses map to higher rates of emotional and behavioral difficulties, giving researchers a better idea of ​​how early trauma shapes human development. Biological aging can occur at a different pace than chronological aging. One way scientists measure biological age is by looking at epigenetics. Epigenetics involves chemical modifications to DNA that change how genes are expressed without changing the underlying…

Read More

A new study raises the question whether there is a biological limit to human endurance that begins long before adulthood, perhaps starting at birth. Researchers are investigating whether birth weight, a known risk factor for disease later in life, may also influence the body’s response to extreme endurance exercise. Research published in Frontiers of ecology and evolutionFor the first time, a group led by biological anthropologist Alison Murray from the University of Victoria has investigated the potential link between birth weight and kidney stress in ultramarathoners. Humans are often described as having an innate capacity for endurance, a trait…

Read More

FAPESP-supported research shows that small doses of the antibiotic minocycline may be helpful in treating panic disorder. Experiments conducted in mice at the State University of São Paulo (UNESP) and in humans at the Federal University of Rio de Janeiro (UFRJ) showed that minocycline is as effective as clonazepam, the most commonly prescribed anti-panic drug and best known by its brand name Rivotril. The study was published in the journal translational psychiatry. The doses of antibiotics needed to treat panic attacks in this study were lower than those used to treat bacterial infections, reducing the chance of bacterial resistance developing.…

Read More

Bristol-Myers Squibb’s growth portfolio is on track to offset declines in legacy products, even as star heart drug Camjos faces new competition. A year ago, in the first quarter of 2025, BMS’s revenue was a perfectly even mix of its old legacy portfolio and new growth products. According to the presentation (PDF), by the first quarter of 2026, growth products will be in development, with new drugs accounting for $6.2 billion of the quarter’s total sales of $11.5 billion. Across more than a dozen growth products, the segment’s 12% sales increase was primarily driven by the obstructive hypertrophic cardiomyopathy (oHCM)…

Read More

A recent study published as a Wharton School research paper provides evidence that people are increasingly relying on artificial intelligence to make decisions, a phenomenon scientists are calling “cognitive capitulation.” This finding suggests that individuals tend to adopt computer-generated answers without thinking critically about them. This habit improves human accuracy when the software is correct, but significantly reduces performance when the system makes mistakes. Since the late 20th century, psychologists have generally divided human cognition into two distinct categories. System 1 represents immediate automatic reactions triggered by instincts and emotions. System 2 involves the deliberate, effortful reflection required to solve…

Read More

WASHINGTON – The Trump administration has withdrawn its nomination of Casey Means to be the next Surgeon General and replaced her with radiologist and Fox News contributor Nicole Safier. The move would be a blow to the Make America Healthy Again movement, which has been pushing for Means’ approval for months. But Safia shares some commonalities with the MAHA movement, including a concern for personal health and skepticism about vaccine mandates. It also shows the limits of the Trump administration’s ability to achieve Senate approval, especially after months of concerns from lawmakers over health issues. The administration has nominated a…

Read More

The House approved a five-year farm bill Thursday after removing a law on liability protections for pesticide manufacturers. The 224-200 vote sets the stage for follow-up action by the Senate, but the Agriculture, Nutrition, and Forestry Committee has yet to introduce any significant measures of its own for food, agriculture, and rural development. Fourteen Democratic senators voted in favor of the bill (HR7567). Three Republicans opposed it: Brian Fitzpatrick of Pennsylvania, Harriet Hageman of Wyoming, and Andrew Garbarino of New York. “This is a great day for American farmers and American consumers,” House Agriculture Committee Chairman Glenn Thompson (R-Pennsylvania) told…

Read More

Healthcare payment software maker Waystar reported first-quarter sales of $313.9 million, a 22% increase from the same period last year, as management reaffirmed its investment in artificial intelligence and innovation. In first-quarter results released Wednesday afternoon, Waystar reported net income of $43.3 million, or GAAP net income of 22 cents per share. The company also reported first-quarter adjusted EBITDA of $135.4 million. The company reported non-GAAP earnings per share of 42 cents, beating analyst estimates of 39 cents per share. Waystar’s first-quarter sales also exceeded Wall Street analysts’ expectations of $311.72 million for the same quarter. Waystar provides healthcare payment…

Read More

Women who have sex on a regular basis may experience fewer of the everyday physical discomforts associated with hormonal changes and aging. A recent study of Japanese women found that those who had sex within the past three months were less likely to experience genital dryness, irritation, and pain in daily life. The results of this study were published in the journal Menoposition. As you move into your last menstrual period, your body’s production of estrogen begins to decrease. Estrogen is the main hormone that helps regulate the female reproductive system and maintains the elasticity and hydration of vaginal tissues.…

Read More

The U.S. Food and Drug Administration has proposed excluding the active ingredients of popular obesity and diabetes drugs from the list of substances that can be used to make certain compounded versions. The agency determined there was no “clinical need” to allow large-scale compounding facilities to manufacture large quantities of the drug, including semaglutide, an ingredient in Novo Nordisk’s Wegovy weight loss drug and Ozempic diabetes drug, and tirzepatide, an ingredient in Eli Lilly’s diabetes drug Moujaro and Zepbound obesity drug. The decision singled out these compounders, known in regulatory parlance as 503B facilities, after growing controversy over the past…

Read More